Skip to contentSkip to Braille Studio

Library / Laws / 116th / hr / H.R. 7674 / Introduced in House

H.R. 7674 — Introduced in House

437 words · about 2 min to read

Download .txt All versions Braille ⠃⠗⠋ Print Cite

I 116th CONGRESS 2d Session H. R. 7674 IN THE HOUSE OF REPRESENTATIVES July 20, 2020 Mr. Beyer (for himself, Ms. Sewell of Alabama, Mr. García of Illinois, Mr. Serrano, Ms. Scanlon, Mr. Horsford, Mr. Connolly, Mr. Perlmutter, Mr. Lipinski, Mr. Cisneros, Ms. Dean, Mr. Pascrell, Mr. Suozzi, Mr. Langevin, Ms. McCollum, Mrs. Axne, Ms. Porter, Mr. Garamendi, Mr. Grijalva, Mrs. Watson Coleman, Ms. Gabbard, Mr. Cárdenas, Mr. Welch, Mrs. Lawrence, Mr. Sablan, Ms. Sherrill, Ms. Spanberger, Mr. Gonzalez of Texas, and Mr. Engel) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To require the Director of the Centers for Disease Control and Prevention to create a standardized method for State, Tribal, and local health departments to report to the Centers with respect to COVID–19, and for other purposes. 1. Short title This Act may be cited as the COVID–19 Data Transparency Act. 2. Standardized method for health department reporting (a) In general Not later than 30 days after the date of enactment of this Act, the Director of the Centers for Disease Control and Prevention shall create a standardized method for State, Tribal, and local health departments to report to the Centers with respect to COVID–19 the following: (1) Daily hospitalizations of patients in the respective jurisdiction with a confirmed or presumed case of COVID–19. (2) Daily numbers of such patients in the intensive care unit. (3) Daily numbers of such patients on ventilators. (4) How long such patients have been in the hospital. (5) Daily numbers of diagnostic and serological tests administered for SARS–CoV–2 with respect to patients in the respective jurisdiction, disaggregated by— (A) the type of test; and (B) the testing positivity rate of each type of test. (6) The sensitivity and specificity of each such type of test. (7) Daily numbers and percentages of contacts traced with respect to patients in the respective jurisdiction. (8) The rate of transmission of SARS–CoV–2 in the respective jurisdiction. (b) Posting by CDC The Director of the Centers for Disease Control and Prevention shall— (1) post the information described in paragraphs (1) through (8) of subsection (a), to the extent such information is in the possession of the Centers, on the public website of the Centers, except that such posting shall exclude any individually identifiable information; and (2) to the extent feasible disaggregate such information by State, Tribal, and local jurisdiction. (c) Updates The Director of the Centers for Disease Control and Prevention— (1) shall, as appropriate, periodically update the method posted under subsection (a); and (2) may revise and expand the reporting categories listed in such subsection.